Chenguang Biotech Group Co akcijos akcijų analizė | Akcijų kaina | Naujienos | 300138.SZ | CNE100000WC5 |

Data	Chenguang Biotech Group Co Akcijų kaina
2024-09-20	7,10 undefined
2024-09-19	7,31 undefined
2024-09-18	7,08 undefined
2024-09-13	7,34 undefined
2024-09-12	7,38 undefined
2024-09-11	7,00 undefined
2024-09-10	7,02 undefined
2024-09-09	7,04 undefined
2024-09-06	7,14 undefined
2024-09-05	7,31 undefined
2024-09-04	7,26 undefined
2024-09-03	7,32 undefined
2024-09-02	7,35 undefined
2024-08-30	7,52 undefined
2024-08-29	7,36 undefined
2024-08-28	7,27 undefined
2024-08-27	7,16 undefined
2024-08-26	7,06 undefined
2024-08-23	7,24 undefined

Data	Chenguang Biotech Group Co Pajamos	Chenguang Biotech Group Co EBIT	Chenguang Biotech Group Co Pelnas
2026e	9,55 mlrd. undefined	783,76 mln. undefined	541,64 mln. undefined
2025e	8,31 mlrd. undefined	671,55 mln. undefined	428,66 mln. undefined
2024e	7,41 mlrd. undefined	511,01 mln. undefined	293,23 mln. undefined
2023	6,87 mlrd. undefined	520,40 mln. undefined	479,72 mln. undefined
2022	6,30 mlrd. undefined	473,52 mln. undefined	434,03 mln. undefined
2021	4,87 mlrd. undefined	410,40 mln. undefined	351,51 mln. undefined
2020	3,91 mlrd. undefined	369,40 mln. undefined	271,50 mln. undefined
2019	3,27 mlrd. undefined	254,10 mln. undefined	193,60 mln. undefined
2018	3,06 mlrd. undefined	181,70 mln. undefined	145,30 mln. undefined
2017	2,77 mlrd. undefined	160,80 mln. undefined	142,80 mln. undefined
2016	2,14 mlrd. undefined	90,40 mln. undefined	92,50 mln. undefined
2015	1,27 mlrd. undefined	63,20 mln. undefined	68,90 mln. undefined
2014	1,21 mlrd. undefined	30,50 mln. undefined	22,40 mln. undefined
2013	1,19 mlrd. undefined	36,10 mln. undefined	10,50 mln. undefined
2012	951,30 mln. undefined	49,40 mln. undefined	58,90 mln. undefined
2011	1,07 mlrd. undefined	82,80 mln. undefined	75,00 mln. undefined
2010	584,10 mln. undefined	77,00 mln. undefined	63,50 mln. undefined
2009	414,00 mln. undefined	63,20 mln. undefined	48,80 mln. undefined
2008	319,60 mln. undefined	51,00 mln. undefined	38,50 mln. undefined
2007	152,50 mln. undefined	21,20 mln. undefined	11,70 mln. undefined

	Pajamos	EBIT	Pelnas
2007	152,50 mln. CNY	21,20 mln. CNY	11,70 mln. CNY
2008	319,60 mln. CNY	51,00 mln. CNY	38,50 mln. CNY
2009	414,00 mln. CNY	63,20 mln. CNY	48,80 mln. CNY
2010	584,10 mln. CNY	77,00 mln. CNY	63,50 mln. CNY
2011	1,07 mlrd. CNY	82,80 mln. CNY	75,00 mln. CNY
2012	951,30 mln. CNY	49,40 mln. CNY	58,90 mln. CNY
2013	1,19 mlrd. CNY	36,10 mln. CNY	10,50 mln. CNY
2014	1,21 mlrd. CNY	30,50 mln. CNY	22,40 mln. CNY
2015	1,27 mlrd. CNY	63,20 mln. CNY	68,90 mln. CNY
2016	2,14 mlrd. CNY	90,40 mln. CNY	92,50 mln. CNY
2017	2,77 mlrd. CNY	160,80 mln. CNY	142,80 mln. CNY
2018	3,06 mlrd. CNY	181,70 mln. CNY	145,30 mln. CNY
2019	3,27 mlrd. CNY	254,10 mln. CNY	193,60 mln. CNY
2020	3,91 mlrd. CNY	369,40 mln. CNY	271,50 mln. CNY
2021	4,87 mlrd. CNY	410,40 mln. CNY	351,51 mln. CNY
2022	6,30 mlrd. CNY	473,52 mln. CNY	434,03 mln. CNY
2023	6,87 mlrd. CNY	520,40 mln. CNY	479,72 mln. CNY
2024e	7,41 mlrd. CNY	511,01 mln. CNY	293,23 mln. CNY
2025e	8,31 mlrd. CNY	671,55 mln. CNY	428,66 mln. CNY
2026e	9,55 mlrd. CNY	783,76 mln. CNY	541,64 mln. CNY

2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e
0,15	0,32	0,41	0,58	1,07	0,95	1,19	1,21	1,27	2,14	2,77	3,06	3,27	3,91	4,87	6,30	6,87	7,41	8,31	9,55
-	109,87	29,78	41,06	83,39	−11,20	24,71	1,77	4,97	68,90	29,53	10,50	6,59	19,82	24,57	29,18	9,15	7,84	12,16	14,93
23,68	23,20	24,40	20,89	14,94	15,88	12,23	10,60	13,73	13,64	12,48	14,10	17,58	16,16	14,36	13,44	11,66	-	-	-
36,00	74,00	101,00	122,00	160,00	151,00	145,00	128,00	174,00	292,00	346,00	432,00	574,00	632,00	700,00	846,00	801,00	0	0	0
21,00	51,00	63,00	77,00	82,00	49,00	36,00	30,00	63,00	90,00	160,00	181,00	254,00	369,00	410,00	473,00	520,00	511,00	671,00	783,00
13,82	15,99	15,22	13,18	7,66	5,15	3,04	2,49	4,97	4,21	5,77	5,91	7,78	9,43	8,41	7,51	7,57	6,90	8,07	8,20
11,00	38,00	48,00	63,00	75,00	58,00	10,00	22,00	68,00	92,00	142,00	145,00	193,00	271,00	351,00	434,00	479,00	293,00	428,00	541,00
-	245,45	26,32	31,25	19,05	−22,67	−82,76	120,00	209,09	35,29	54,35	2,11	33,10	40,41	29,52	23,65	10,37	−38,83	46,08	26,40
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
173,10	235,20	254,90	332,20	422,30	422,30	422,30	422,30	509,40	513,70	512,90	513,70	511,90	490,00	528,51	532,77	532,02	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2020	2021	2022	2023

0,00	0,01	0,04	0,43	0,15	0,04	0,08	0,13	0,31	0,27	0,13	0,19	0,10	0,21	0,21	0,76	1,41	1,74
25,60	58,80	39,30	79,70	74,70	68,40	76,80	81,10	128,90	245,40	217,30	280,30	291,00	295,10	295,10	393,60	303,24	463,60
23,10	40,70	10,90	17,30	82,50	82,10	131,20	62,40	29,40	65,90	72,50	175,70	162,10	119,32	119,30	131,99	144,17	160,86
0,06	0,15	0,14	0,35	0,30	0,63	0,68	0,53	0,80	1,03	1,47	1,50	1,92	1,79	1,79	2,23	2,03	3,20
0,01	0,04	0,03	0,05	0,10	0,07	0,04	0,09	0,08	0,16	0,14	0,19	0,72	0,50	0,50	0,46	1,03	0,80
0,13	0,29	0,25	0,92	0,71	0,89	1,01	0,90	1,35	1,77	2,02	2,34	3,19	2,91	2,91	3,98	4,93	6,37
0,04	0,08	0,11	0,18	0,34	0,47	0,50	0,48	0,50	0,58	0,67	0,78	0,92	1,24	1,24	1,50	1,54	1,70
0,20	0,20	0	0	0	0	6,90	7,00	6,70	13,00	37,80	88,40	153,40	168,86	168,90	178,37	104,23	112,95
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	77,56	0
10,90	12,30	31,70	38,90	59,90	80,00	92,20	96,00	116,60	115,10	120,50	123,60	143,70	257,72	257,70	268,83	315,05	316,42
0,60	0,90	2,20	2,20	2,20	2,20	0,60	0,60	0,60	0,60	0,60	0,60	0,60	0,59	0,60	0,59	0,59	0,59
0,10	0,50	2,40	2,60	3,30	5,10	20,90	15,60	17,50	15,50	24,40	24,20	93,00	71,54	71,50	32,76	36,39	44,79
0,06	0,09	0,15	0,23	0,40	0,56	0,62	0,60	0,64	0,73	0,85	1,02	1,31	1,74	1,74	1,98	2,07	2,17
0,19	0,39	0,40	1,15	1,12	1,45	1,63	1,51	1,99	2,49	2,87	3,36	4,51	4,65	4,65	5,96	7,00	8,54

50,00	50,00	66,80	89,80	89,80	179,60	179,60	179,60	216,60	262,10	367,00	513,70	511,90	520,31	520,30	532,77	532,77	532,77
0	0	0,09	0,72	0,72	0,63	0,64	0,64	0,94	0,92	0,81	0,66	0,65	0,75	0,75	1,03	1,02	1,02
0,04	0,08	0,04	0,10	0,16	0,20	0,19	0,21	0,28	0,36	0,48	0,60	0,75	1,00	1,00	1,29	1,66	2,06
0	0	0	0	−11,50	−14,10	−22,20	−22,90	−22,70	−19,20	−23,80	−27,50	−28,10	26,92	26,90	−68,33	−51,98	−44,38
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1,13	0,56	0,18
0,09	0,13	0,19	0,91	0,96	0,99	0,99	1,01	1,42	1,52	1,64	1,75	1,89	2,30	2,30	2,79	3,16	3,57
22,80	107,90	15,10	20,90	35,50	82,40	44,90	54,90	57,20	36,00	71,10	83,70	162,30	33,26	33,30	36,09	55,96	79,53
3,80	7,00	3,50	4,80	5,10	5,50	5,30	5,30	11,00	22,90	33,90	30,10	40,10	73,51	73,50	115,47	139,91	126,15
16,90	47,00	−0,40	−15,30	27,00	56,00	53,20	56,40	125,10	151,60	190,70	120,60	180,90	275,06	275,10	391,17	517,27	396,64
0,04	0,07	0,17	0,20	0,07	0,28	0,48	0,33	0,31	0,69	0,89	1,31	2,05	1,04	1,04	1,84	2,04	2,60
0	0	0	2,70	2,70	0	0	0	6,60	7,20	8,40	9,20	0	6,41	6,40	300,58	0,83	750,78
0,08	0,23	0,18	0,21	0,14	0,43	0,58	0,44	0,51	0,91	1,20	1,56	2,43	1,43	1,43	2,68	2,76	3,95
0	0	0	0	0	0	0	0	0	0	0	0	0,26	1,03	1,03	0,31	0,77	0,87
0	0	0	0	0	0	0	0	0	0	0	0	8,90	12,43	12,40	14,56	16,64	16,57
4,50	5,10	7,80	5,20	10,80	22,50	57,90	54,70	57,20	55,20	52,90	61,10	66,50	125,23	125,20	169,39	161,78	169,95
0,00	0,01	0,01	0,01	0,01	0,02	0,06	0,05	0,06	0,06	0,05	0,06	0,33	1,17	1,17	0,49	0,95	1,06
0,09	0,24	0,19	0,22	0,15	0,45	0,64	0,50	0,56	0,97	1,25	1,62	2,77	2,59	2,59	3,17	3,71	5,01
0,17	0,36	0,38	1,12	1,10	1,44	1,63	1,51	1,98	2,49	2,88	3,37	4,66	4,89	4,89	5,96	6,87	8,57

2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2020	2021	2022
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	436,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	144,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	−2,00
−9,00	−10,00	0	−2,00	0	−57,00	−67,00	−76,00	−98,00	−173,00	−67,00	−282,00	−361,00	−192,00	−192,00	−237,00	−305,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52,00	67,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
−3,00	−10,00	18,00	−6,00	−3,00	−20,00	9,00	0	−4,00	−8,00	−7,00	13,00	49,00	20,00	20,00	31,00	46,00
−23,00	9,00	27,00	−190,00	82,00	−142,00	−36,00	273,00	−64,00	−321,00	−145,00	−56,00	−24,00	529,00	529,00	63,00	734,00
−13,00	−26,00	−66,00	−97,00	−181,00	−134,00	−76,00	−36,00	−74,00	−94,00	−127,00	−139,00	−265,00	−436,00	−436,00	−280,00	−176,00
−13,00	−35,00	−73,00	−102,00	−181,00	−134,00	−76,00	−36,00	−75,00	−98,00	−158,00	−189,00	−322,00	−442,00	−442,00	−264,00	−696,00
0	−9,00	−6,00	−5,00	0	0	0	0	0	−3,00	−31,00	−50,00	−56,00	−5,00	−5,00	16,00	−520,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
−4,00	33,00	81,00	32,00	−134,00	207,00	198,00	−165,00	−27,00	347,00	248,00	377,00	926,00	68,00	−551,00	805,00	378,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
19,00	30,00	73,00	683,00	−172,00	162,00	160,00	−186,00	258,00	285,00	306,00	218,00	342,00	242,00	242,00	540,00	39,00
23,00	−2,00	−8,00	659,00	−15,00	−12,00	0	0	303,00	−35,00	100,00	−80,00	−481,00	360,00	887,00	−155,00	−195,00
0	0	0	−8,00	−22,00	−31,00	−38,00	−21,00	−16,00	−26,00	−42,00	−78,00	−102,00	−93,00	−93,00	−109,00	−143,00
−0,03	0,03	0,04	0,21	−0,19	−0,18	0,07	0,40	0,16	−0,27	−0,07	0,19	0,28	1,03	1,03	0,61	1,07
−36,20	−16,90	−39,70	−288,00	−99,50	−276,60	−113,10	236,40	−138,80	−416,40	−273,70	−195,70	−290,00	92,53	92,50	−216,92	558,78
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Chenguang Biotech Group Co Bruto marža	Chenguang Biotech Group Co Pelnas-martža	Chenguang Biotech Group Co EBIT marža	Chenguang Biotech Group Co Pelnas-martža
2026e	11,67 %	8,21 %	5,67 %
2025e	11,67 %	8,08 %	5,16 %
2024e	11,67 %	6,90 %	3,96 %
2023	11,67 %	7,57 %	6,98 %
2022	13,45 %	7,52 %	6,89 %
2021	14,37 %	8,42 %	7,21 %
2020	16,17 %	9,44 %	6,94 %
2019	17,59 %	7,78 %	5,93 %
2018	14,12 %	5,93 %	4,74 %
2017	12,51 %	5,80 %	5,15 %
2016	13,67 %	4,22 %	4,32 %
2015	13,73 %	4,99 %	5,44 %
2014	10,66 %	2,53 %	1,86 %
2013	12,29 %	3,04 %	0,89 %
2012	15,97 %	5,19 %	6,19 %
2011	14,99 %	7,73 %	7,00 %
2010	21,01 %	13,18 %	10,87 %
2009	24,59 %	15,27 %	11,79 %
2008	23,25 %	15,96 %	12,05 %
2007	23,61 %	13,90 %	7,67 %

	Bruto marža	EBIT marža	Pelnas-martža
2007	23,61 %	13,90 %	7,67 %
2008	23,25 %	15,96 %	12,05 %
2009	24,59 %	15,27 %	11,79 %
2010	21,01 %	13,18 %	10,87 %
2011	14,99 %	7,73 %	7,00 %
2012	15,97 %	5,19 %	6,19 %
2013	12,29 %	3,04 %	0,89 %
2014	10,66 %	2,53 %	1,86 %
2015	13,73 %	4,99 %	5,44 %
2016	13,67 %	4,22 %	4,32 %
2017	12,51 %	5,80 %	5,15 %
2018	14,12 %	5,93 %	4,74 %
2019	17,59 %	7,78 %	5,93 %
2020	16,17 %	9,44 %	6,94 %
2021	14,37 %	8,42 %	7,21 %
2022	13,45 %	7,52 %	6,89 %
2023	11,67 %	7,57 %	6,98 %
2024e	11,67 %	6,90 %	3,96 %
2025e	11,67 %	8,08 %	5,16 %
2026e	11,67 %	8,21 %	5,67 %

Data	Chenguang Biotech Group Co Pardavimai vienai akcijai	Chenguang Biotech Group Co EBIT vienai akcijai	Chenguang Biotech Group Co Pelnas vienai akcijai
2026e	24,49 undefined	0 undefined	1,39 undefined
2025e	21,31 undefined	0 undefined	1,10 undefined
2024e	19,00 undefined	0 undefined	0,75 undefined
2023	12,92 undefined	0,98 undefined	0,90 undefined
2022	11,82 undefined	0,89 undefined	0,81 undefined
2021	9,22 undefined	0,78 undefined	0,67 undefined
2020	7,99 undefined	0,75 undefined	0,55 undefined
2019	6,38 undefined	0,50 undefined	0,38 undefined
2018	5,96 undefined	0,35 undefined	0,28 undefined
2017	5,40 undefined	0,31 undefined	0,28 undefined
2016	4,17 undefined	0,18 undefined	0,18 undefined
2015	2,49 undefined	0,12 undefined	0,14 undefined
2014	2,86 undefined	0,07 undefined	0,05 undefined
2013	2,81 undefined	0,09 undefined	0,02 undefined
2012	2,25 undefined	0,12 undefined	0,14 undefined
2011	2,54 undefined	0,20 undefined	0,18 undefined
2010	1,76 undefined	0,23 undefined	0,19 undefined
2009	1,62 undefined	0,25 undefined	0,19 undefined
2008	1,36 undefined	0,22 undefined	0,16 undefined
2007	0,88 undefined	0,12 undefined	0,07 undefined

	Pardavimai vienai akcijai	EBIT vienai akcijai	Pelnas vienai akcijai
2007	0,88 CNY	0,12 CNY	0,07 CNY
2008	1,36 CNY	0,22 CNY	0,16 CNY
2009	1,62 CNY	0,25 CNY	0,19 CNY
2010	1,76 CNY	0,23 CNY	0,19 CNY
2011	2,54 CNY	0,20 CNY	0,18 CNY
2012	2,25 CNY	0,12 CNY	0,14 CNY
2013	2,81 CNY	0,09 CNY	0,02 CNY
2014	2,86 CNY	0,07 CNY	0,05 CNY
2015	2,49 CNY	0,12 CNY	0,14 CNY
2016	4,17 CNY	0,18 CNY	0,18 CNY
2017	5,40 CNY	0,31 CNY	0,28 CNY
2018	5,96 CNY	0,35 CNY	0,28 CNY
2019	6,38 CNY	0,50 CNY	0,38 CNY
2020	7,99 CNY	0,75 CNY	0,55 CNY
2021	9,22 CNY	0,78 CNY	0,67 CNY
2022	11,82 CNY	0,89 CNY	0,81 CNY
2023	12,92 CNY	0,98 CNY	0,90 CNY
2024e	19,00 CNY	0 CNY	0,75 CNY
2025e	21,31 CNY	0 CNY	1,10 CNY
2026e	24,49 CNY	0 CNY	1,39 CNY

	Akcijų skaičius
2007	173,10 mln. Aktien
2008	235,20 mln. Aktien
2009	254,90 mln. Aktien
2010	332,20 mln. Aktien
2011	422,30 mln. Aktien
2012	422,30 mln. Aktien
2013	422,30 mln. Aktien
2014	422,30 mln. Aktien
2015	509,40 mln. Aktien
2016	513,70 mln. Aktien
2017	512,90 mln. Aktien
2018	513,70 mln. Aktien
2019	511,90 mln. Aktien
2020	490,00 mln. Aktien
2021	528,51 mln. Aktien
2022	532,77 mln. Aktien
2023	532,02 mln. Aktien
2024e	532,02 mln. Aktien
2025e	532,02 mln. Aktien
2026e	532,02 mln. Aktien

Data	Chenguang Biotech Group Co Dividendas
2026e	0,18 undefined
2025e	0,18 undefined
2024e	0,18 undefined
2023	0,16 undefined
2022	0,13 undefined
2021	0,10 undefined
2020	0,05 undefined
2019	0,08 undefined
2018	0,06 undefined
2017	0,04 undefined
2016	0,02 undefined
2015	0,01 undefined
2014	0,00 undefined
2013	0,04 undefined
2012	0,04 undefined
2011	0,03 undefined

	Dividendas	Dividenda (įvertinimas)
2007	0 CNY	0 CNY
2008	0 CNY	0 CNY
2009	0 CNY	0 CNY
2010	0 CNY	0 CNY
2011	0,03 CNY	0 CNY
2012	0,04 CNY	0 CNY
2013	0,04 CNY	0 CNY
2014	0,00 CNY	0 CNY
2015	0,01 CNY	0 CNY
2016	0,02 CNY	0 CNY
2017	0,04 CNY	0 CNY
2018	0,06 CNY	0 CNY
2019	0,08 CNY	0 CNY
2020	0,05 CNY	0 CNY
2021	0,10 CNY	0 CNY
2022	0,13 CNY	0 CNY
2023	0,16 CNY	0 CNY
2024e	0 CNY	0,18 CNY
2025e	0 CNY	0,18 CNY
2026e	0 CNY	0,18 CNY

Data	Chenguang Biotech Group Co Išmokėjimo santykis
2026e	14,28 %
2025e	14,70 %
2024e	14,78 %
2023	13,36 %
2022	15,96 %
2021	15,04 %
2020	9,09 %
2019	21,05 %
2018	20,41 %
2017	14,57 %
2016	11,83 %
2015	4,57 %
2014	8,60 %
2013	212,50 %
2012	30,36 %
2011	17,72 %
2010	13,36 %
2009	13,36 %
2008	13,36 %
2007	13,36 %

	Išmokėjimo santykis
2007	13,36 %
2008	13,36 %
2009	13,36 %
2010	13,36 %
2011	17,72 %
2012	30,36 %
2013	212,50 %
2014	8,60 %
2015	4,57 %
2016	11,83 %
2017	14,57 %
2018	20,41 %
2019	21,05 %
2020	9,09 %
2021	15,04 %
2022	15,96 %
2023	13,36 %
2024e	14,78 %
2025e	14,70 %
2026e	14,28 %

Data	EPS-prognozė	EPS-Faktinis	Pranešimo ketvirtis
2023-12-31	0,19	0,15 (−22,01 %)	2023 Q4
2023-06-30	0,42	0,31 (−27,26 %)	2023 Q2
2022-12-31	0,20	0,19 (−5,53 %)	2022 Q4
2022-06-30	0,23	0,25 (10,64 %)	2022 Q2
2022-03-31	0,21	0,20 (−3,56 %)	2022 Q1
2021-12-31	0,15	0,18 (17,85 %)	2021 Q4
2021-09-30	0,14	0,13 (−3,92 %)	2021 Q3
2021-06-30	0,23	0,23 (0,08 %)	2021 Q2
2012-09-30	0,08	0,00 (−97,92 %)	2012 Q3
2012-06-30	0,08	0,04 (−47,19 %)	2012 Q2
2011-12-31	0,04	0,05 (5,06 %)	2011 Q4

%	Pavadinimas	Akcijos	Pokytis	Data
4,11603 %	Li (Yuezhai)	16 053 365	0	2023-09-30
3,84481 %	ICBC Credit Suisse Asset Management Co. Ltd.	14 995 554	0	2023-09-30
3,04540 %	Sun (Ying)	11 877 700	0	2023-09-30
25,17714 %	Lu (Qingguo)	98 196 051	0	2023-09-30
2,82126 %	Gao (Peijie)	11 003 500	0	2023-09-30
2,34230 %	Guan (Qingbin)	9 135 437	0	2023-09-30
2,14625 %	Fullgoal Fund Management Co., Ltd.	8 370 836	13 000	2023-12-31
2,14083 %	Zhong Ou Asset Management Co., Ltd.	8 349 659	−2 361 800	2023-06-30
2,12148 %	Zhou (Jing)	8 274 226	0	2023-09-30
2,11119 %	Ning (Zhanyang)	8 234 082	79 700	2023-09-30
2,05117 %	Zheshang Fund Management Co., Ltd.	8 000 000	2 900 000	2023-09-30
1,79478 %	CIB Fund Management Co., Ltd.	7 000 000	−3 580 426	2023-09-30
1,79478 %	Dong (Haotian)	7 000 000	0	2023-09-30
1,00238 %	China Post & Capital Fund Management Co., Ltd.	3 909 500	3 909 500	2023-12-31
0,98175 %	JPMorgan Asset Management (China) Company Limited.	3 829 013	−1 152 184	2023-12-31
0,92342 %	Lian (Yunhe)	3 601 541	−1 148 000	2023-06-30
0,81001 %	Taikang Asset Management Co., Ltd.	3 159 200	3 087 800	2023-06-30
0,58750 %	Pzena Investment Management, LLC	2 291 366	0	2023-06-30
0,54156 %	HSBC JinTrust Fund Management Co., Ltd.	2 112 200	152 500	2023-12-31
0,51647 %	Florida State Board of Administration	2 014 356	2 014 356	2022-09-30
0,45288 %	AEGON-INDUSTRIAL Fund Management Co., Ltd.	1 766 341	0	2023-06-30
0,43295 %	Penghua Fund Management Co., Ltd.	1 688 600	1 617 300	2023-06-30
0,33155 %	Baoying Fund Management Co., Ltd.	1 293 100	−84 500	2023-12-31
0,28204 %	Jyah Asset Management.Co.,LTD	1 100 000	1 100 000	2023-06-30
0,25088 %	Tianhong Asset Management Co., Ltd.	978 500	−9 200	2023-12-31
0,18873 %	China Southern Asset Management Co. Ltd.	736 100	−843 600	2023-06-30
0,16358 %	Harvest Fund Management Co., Ltd.	638 000	459 500	2023-12-31
0,14684 %	Manulife Fund Management Co., Ltd.	572 700	138 100	2023-06-30
0,14560 %	Li (Fengfei)	567 883	−188 000	2023-07-07
0,14301 %	Dimensional Fund Advisors, L.P.	557 755	−22 900	2024-02-29
0,13915 %	Victory Capital Management Inc.	542 700	−1 135 800	2023-12-31
0,13681 %	GF Fund Management Co., Ltd.	533 600	100 000	2023-12-31
0,13259 %	Nuode Asset Management Company Limited	517 136	517 136	2023-06-30
0,06761 %	China Merchants Fund Management Co. Ltd.	263 700	50 800	2023-12-31
0,06666 %	CITIC Prudential Fund Management Co., Ltd.	260 000	260 000	2023-06-30
0,05661 %	Ping An Fund Management Company Limited	220 800	220 800	2023-06-30
0,05207 %	Chang Xin Asset Management Co., Ltd.	203 100	−17 600	2023-12-31
0,04756 %	China Asset Management Co., Ltd.	185 500	23 800	2023-12-31
0,04169 %	Western Leadbank Fund Management Co., Ltd.	162 600	162 600	2023-06-30
0,03656 %	Huashang Fund Management Co., Ltd.	142 600	142 600	2023-06-30
0,03590 %	PengYang Asset Management Co., Ltd	140 000	14 000	2023-06-30
0,03036 %	Great Wall Fund Management Co., Ltd.	118 412	−58 900	2023-12-31
0,02354 %	Yinhua Fund Management Co., Ltd.	91 800	−13 800	2023-12-31
0,02226 %	Hwabao WP Fund Management Co., Ltd.	86 800	86 800	2023-06-30
0,02210 %	E Fund Management Co. Ltd.	86 200	1 900	2023-12-31
0,01902 %	Gao (Wei)	74 186	0	2023-06-30
0,01833 %	Dimensional Fund Advisors, Ltd.	71 500	0	2024-02-29
0,01358 %	Zhao (Tao)	52 960	0	2023-06-30
0,00844 %	Green Fund Management Co., Ltd.	32 900	32 900	2023-06-30
0,00769 %	Changsheng Fund Management Co., Ltd.	30 000	1 800	2023-06-30
0,00761 %	Lion Fund Management Co., Ltd.	29 700	−263 100	2023-06-30
0,00683 %	HFT Investment Management Co., Ltd.	26 620	−800	2023-12-31
0,00677 %	CCB Principal Asset Management Co., Ltd.	26 400	26 400	2023-12-31
0,00667 %	Shanghai Haitong Securities Asset Management Ltd.	26 000	−4 000	2023-06-30
0,00579 %	Xingyin Fund Management Co., Ltd.	22 600	−21	2022-12-31
0,00569 %	Sealand Securities Co., Ltd.	22 200	6 600	2023-06-30
0,00485 %	State Street Global Advisors (US)	18 900	0	2024-02-29
0,00344 %	Topsperity Fund Management Co., Ltd.	13 400	13 400	2023-06-30
0,00344 %	Bosera Asset Management Co., Ltd.	13 400	−1 000	2023-12-31
0,00333 %	SWS MU Fund Management Co., Ltd.	13 000	−6 200	2023-06-30
0,00313 %	Dongxing Asset Management Co., Ltd.	12 200	−3 700	2023-12-31
0,00282 %	Hony Horizon Fund Management Co., Ltd.	11 000	11 000	2023-06-30
0,00259 %	Zheshang Securities Asset Management Company Limited	10 100	10 100	2023-06-30
0,00254 %	First Seafront Fund Management Co., Ltd.	9 901	−90 099	2023-06-30
0,00131 %	Broad Asset Management Co., Ltd	5 100	−480 000	2023-06-30
0,00051 %	ZhongRong Fund Mgmt Co., Ltd	2 000	2 000	2023-06-30
0,00038 %	Dongxing Securities Investment Co., Ltd.	1 500	−3 200	2023-06-30
0,00003 %	Everbright PGIM Fund Management Co., Ltd.	100	−57 900	2023-12-31
0 %	Bank of Beijing Scotiabank Asset Management Co., Ltd.	0	−400 000	2023-06-30
0 %	Taiping Fund Management Co., Ltd.	0	−1 500	2023-06-30
0 %	Sophus Capital	0	−1 325 702	2023-12-31
0 %	JT Asset Management Co., Ltd.	0	−1 463 647	2022-12-31
0 %	Truvalue Asset Management Co., Ltd.	0	−10 900	2022-12-31
0 %	Beixin Ruifeng Fund Management Co., Ltd.	0	−84 000	2022-12-31
0 %	Donghai Funds Management Co., Ltd.	0	−34 000	2023-12-31
0 %	GFund Management Co., Ltd.	0	−300	2022-12-31
0 %	Allianz Global Investors U.S. LLC_NLE	0	−45 600	2023-06-30
0 %	BOC International (China) Ltd.	0	−15 000	2022-12-31
0 %	Goldstate Capital Fund Management Co., Ltd.	0	−54 748	2023-06-30
0 %	China Universal Asset Management Co., Ltd.	0	−241 600	2022-12-31
0 %	Bank of Communications Schroder Fund Management Co., Ltd.	0	−2 200	2023-06-30
0 %	Huatai-PineBridge Fund Management Co., Ltd.	0	−53 600	2023-06-30
0 %	INVESCO Great Wall Fund Management Co. Ltd.	0	−2 242 390	2023-06-30
0 %	Dacheng Fund Management Co., Ltd.	0	−1 500	2023-12-31
0 %	UBS SDIC Fund Management Co., Ltd.	0	−36 200	2022-12-31
0 %	Wanjia Asset Management Co., Ltd.	0	−2 000	2023-06-30
0 %	Galaxy Asset Management Co., Ltd.	0	−270 000	2023-12-31
0 %	SEI Investments Management Corporation	0	−27 300	2023-11-30
0 %	BOCI-Prudential Asset Management Ltd.	0	−22 400	2022-12-31
0 %	PineBridge Investments Asia Limited	0	−17 600	2023-01-31
0 %	Harding Loevner LP	0	−321 900	2023-12-31
0 %	Invesco Hong Kong Limited	0	−19 000	2023-09-30
0 %	Allianz Global Investors GmbH	0	−45 600	2023-06-30
0 %	Lazard Asset Management, L.L.C.	0	−745 675	2023-12-31
0 %	Northeast Ronghui Securities Asset Management Co., Ltd.	0	−16 800	2022-12-31
0 %	Tibet Eastmoney Fund Management Co., Ltd.	0	−67 800	2023-06-30
0 %	AVIC Fund Management Co., Ltd.	0	−15 100	2022-12-31
0 %	VanEck Investments Ltd.	0	−304 900	2023-06-30

What values and corporate philosophy does Chenguang Biotech Group Co represent?

Chenguang Biotech Group Co Ltd represents a set of core values and corporate philosophy that guides its operations. The company is committed to innovation, excellence, and sustainability in the biotech industry. Chenguang Biotech Group Co Ltd highly values research and development, constantly striving to introduce new and high-quality products to the market. With a customer-centric approach, the company focuses on meeting the evolving needs of its clients. Furthermore, Chenguang Biotech Group Co Ltd emphasizes ethical and responsible practices throughout its operations, ensuring integrity, transparency, and compliance with regulatory standards. These values and corporate philosophy are embedded in the company's mission to contribute to the advancement of the biotech sector.

In which countries and regions is Chenguang Biotech Group Co primarily present?

Chenguang Biotech Group Co Ltd is primarily present in China.

What significant milestones has the company Chenguang Biotech Group Co achieved?

Chenguang Biotech Group Co Ltd has achieved several significant milestones. Firstly, the company successfully established itself as a leading player in the biotech industry with a strong reputation for quality and innovation. Additionally, Chenguang Biotech Group Co Ltd expanded its global presence by entering into strategic partnerships and collaborations with key industry players. Moreover, the company made notable advancements in research and development, resulting in the launch of groundbreaking products that have revolutionized the market. These achievements have further solidified Chenguang Biotech Group Co Ltd's position as a trusted and influential company in the biotech sector.

What is the history and background of the company Chenguang Biotech Group Co?

Chenguang Biotech Group Co Ltd is a renowned biotechnology company with a rich history and background. Established in 1996, the company has become a leading player in the biotech industry, specializing in the research, development, and production of natural and organic ingredients. With a strong focus on innovation and quality, Chenguang Biotech Group has achieved impressive growth over the years. The company is committed to sustainable development and operates with strict adherence to international standards. Chenguang Biotech Group's wide range of products caters to various industries, including pharmaceuticals, food and beverages, cosmetics, and more. With its stellar reputation and dedication to excellence, Chenguang Biotech Group continues to thrive in the biotech market.

Who are the main competitors of Chenguang Biotech Group Co in the market?

The main competitors of Chenguang Biotech Group Co Ltd in the market include companies such as Tiancheng Pharmaceutical, Guilin Layn Natural Ingredients Corp, and Jiaxing Zhonghua Chemical Co Ltd.

In which industries is Chenguang Biotech Group Co primarily active?

Chenguang Biotech Group Co Ltd is primarily active in the biotechnology industry.

What is the business model of Chenguang Biotech Group Co?

The business model of Chenguang Biotech Group Co Ltd is focused on the production and distribution of natural biochemical products. The company specializes in the research, development, and manufacturing of a wide range of products derived from biological fermentation, such as amino acids, vitamins, and feed additives. Chenguang Biotech Group Co Ltd aims to meet the growing demand for natural and sustainable solutions in industries such as food, agriculture, pharmaceuticals, and animal nutrition. With a strong commitment to innovation and quality, the company strives to provide customers with high-value, environmentally friendly products.

Koks yra Chenguang Biotech Group Co 2024 KGV?

Chenguang Biotech Group Co KGV yra 12,88.

Koks Chenguang Biotech Group Co 2024 KUV?

Chenguang Biotech Group Co KUV yra 0,51.

Koks yra Chenguang Biotech Group Co AlleAktien kokybės įvertinimas?

AlleAktien kokybės įvertis Chenguang Biotech Group Co yra 7/10.

Koks yra Chenguang Biotech Group Co 2024 pajamų dydis?

tikėtina Chenguang Biotech Group Co pardavimai yra 7,41 mlrd. CNY.

Kokia yra Chenguang Biotech Group Co 2024 pelnas?

tikėtina Chenguang Biotech Group Co pelnas yra 293,23 mln. CNY.

Ką daro Chenguang Biotech Group Co?

Chenguang Biotech Group Co Ltd is a leading Chinese manufacturer of biotechnology products. The company was founded in 1996 and is headquartered in the city of Lianyungang, Jiangsu Province. The business model of Chenguang Biotech Group Co Ltd is based on the production and sale of various biotechnology products for the food, cosmetics, medical, and agriculture sectors. In the food sector, the company produces a variety of flavorings, sweeteners, and dietary supplements. The product range includes Stevia, a plant-based alternative to sugar, as well as various flavors for food and beverages such as coffee, tea, and alcohol. These products are used in the food industry to enhance the taste and aroma of food. In the cosmetics sector, Chenguang Biotech produces various ingredients for cosmetic products such as face creams, anti-aging products, and makeup. These include hyaluronic acid, collagen, and various vitamins. These ingredients are used by many leading companies in the cosmetics industry worldwide to improve skin care products and support skin regeneration. In the medical field, Chenguang Biotech Group Co Ltd produces various pharmaceuticals and pharmaceutical intermediates. These include active ingredients for cancer drugs, analgesics, antibiotics, and various vaccines. Chenguang Biotech's products are sold worldwide and help improve the health of millions of people. In the agriculture sector, the company produces various products such as fertilizers, pesticides, and animal feed. These products help increase crop and animal production and contribute to food security. The company works closely with farmers to understand their needs and offer products that meet their requirements. Under the business model of Chenguang Biotech Group Co Ltd, all steps from raw material procurement, production, and quality assurance to distribution are carried out by experienced employees in the company. The company places great emphasis on quality and safety and has obtained all necessary certifications and approvals. The company aims to develop and manufacture innovative products that contribute to improving people's lives. Through investment in research and development, the company aims to expand its product range and strengthen its competitive position. Overall, the business model of Chenguang Biotech Group Co Ltd is very diverse and offers a variety of products for different industries. The company is well positioned to benefit from the strong growth of the biotechnology industry and has a strong market position in Asia and beyond.

Kokia yra Chenguang Biotech Group Co dividendė?

Chenguang Biotech Group Co moka dividendą 0,13 CNY, kuris yra paskirstytas per išmokas per metus.

Kiek kartų Chenguang Biotech Group Co moka dividendą?

Dividenda šiuo metu negali būti apskaičiuota Chenguang Biotech Group Co arba įmonė dividendų nemoka.

Kas yra Chenguang Biotech Group Co ISIN?

Chenguang Biotech Group Co ISIN yra CNE100000WC5.

Kas yra Chenguang Biotech Group Co Tickeris?

Chenguang Biotech Group Co akcijų simbolis yra 300138.SZ.

Kiek dividendų moka Chenguang Biotech Group Co?

Per paskutinius 12 mėnesių Chenguang Biotech Group Co išmokėjo dividendą, kurios dydis siekė 0,16 CNY . Tai atitinka maždaug 2,25 % dividendų grąžą. Artimiausiems 12 mėnesiams Chenguang Biotech Group Co tikėtina išmokės dividendus, kurie sudarys 0,18 CNY.

Kokia yra Chenguang Biotech Group Co dividendų grąža?

Chenguang Biotech Group Co šiuo metu yra 2,25 % dydžio dividendų grąža.

Kada Chenguang Biotech Group Co moka dividendus?

Chenguang Biotech Group Co moka dividendus kas ketvirtį. Jie išmokami gegužė, liepa, birželis, liepa mėnesiais.

Kokia saugi yra Chenguang Biotech Group Co dividendų išmokėjimas?

Chenguang Biotech Group Co per paskutiniuosius 16 metus kiekvienais metais mokėjo dividendus.

Kokia yra Chenguang Biotech Group Co dividendų suma?

Artimiausiems 12 mėnesiams tikimasi dividendų, kurių dydis yra 0,18 CNY. Tai atitinka 2,52 % dividendų grąžos procentą.

Kokiame sektoriuje yra Chenguang Biotech Group Co?

Chenguang Biotech Group Co priskiriamas sektoriui "Neciklinis vartojimas".

Wann musste ich die Aktien von Chenguang Biotech Group Co kaufen, um die vorherige Dividende zu erhalten?

Norėdamas gauti paskutinį Chenguang Biotech Group Co dividendą nuo 2024-06-13, kurio dydis yra 0,13 CNY, turėjai turėti akciją savo depozite prieš ex-dieną, kuri buvo 2024-06-13.

Kada Chenguang Biotech Group Co paskutinį kartą mokėjo dividendą?

Paskutinės dividendų išmokėjimas įvyko 2024-06-13.

Kokia buvo Chenguang Biotech Group Co dividendų suma 2023 metais?

2023 metais Chenguang Biotech Group Co išmokėjo 0,13 CNY dividendų.

Kokia valiuta Chenguang Biotech Group Co moka dividendus?

Chenguang Biotech Group Co dividendai yra mokami CNY.

Chenguang Biotech Group Co Akcijų kodas	Chenguang Biotech Group Co FIGI
300138:CH	BBG0015SV7L7
300138:CS	BBG0015W98T3
300138:C2	BBG0112LX3S4

Padaryk geriausias savo gyvenimo investicijas fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Kursas

Akcijos kaina

Akcijų kodas300138.SZ

ISINCNE100000WC5

Chenguang Biotech Group Co akcijų kaina

Kursas

Apžvalga

Intraday funkcija

Bendroji grąža ir santykinė kainų pokyčiai

Interpretacija ir investavimas

Chenguang Biotech Group Co Akcijų istorija

Chenguang Biotech Group Co akcijų apyvarta, EBIT, pelnas CNE100000WC5 ·

Pajamos, pelnas & EBIT

Supratimas apie pajamas, EBIT ir pelną

Metinė analizė ir palyginimai

Išnaudoti lūkesčius investuojant

Investicijų įžvalgos

Chenguang Biotech Group Co Pajamų, pelno ir EBIT istorija.

Chenguang Biotech Group Co Akcijų rodikliai

GuV

Pajamos ir augimas

Bruto marža

EBIT ir EBIT marža

Pajamos ir jų augimas

Leidžiamų akcijų skaičius

Metinių duomenų palyginimo interpretacija

Lūkesčiai ir prognozės

Balansas

Balanso supratimas

Turtas

Įsipareigojimai

Nuosavas kapitalas

Metų po metų analizė

Duomenų interpretacija

Chenguang Biotech Group Co Akcijos Maržos CNE100000WC5 ·

Margen

Supratimas apie bruto maržą

EBIT maržos analizė

Pardavimų maržos įžvalgos

Lūkesčių interpretavimas

Lyginamoji analizė

Chenguang Biotech Group Co Maržų istorija

Chenguang Biotech Group Co akcijos apyvarta, EBIT, pelnas vienai akcijai CNE100000WC5 ·

Pardavimai, EBIT ir Pelnas vienai akcijai

Pajamos vienai akcijai

EBIT vienai akcijai

Pelnas vienai akcijai

Tikėtinos vertės

Chenguang Biotech Group Co Pardavimų, pelno ir EBIT istorija vienai akcijai

Chenguang Biotech Group Co akcija ir akcijų analizė

Chenguang Biotech Group Co vertinimas pagal Fair Value

Fair Value

Supratimas apie Fair Value

Pajamų pagrindu skaičiuojamas Fair Value

Apyvartos pagrindu skaičiuojamas Fair Value

Dividendų pagrindu skaičiuojamas Fair Value

Lūkesčiai ir prognozės

Palyginamoji analizė

Chenguang Biotech Group Co įvertinimas pagal istorinį P/E, EBIT ir P/S

Chenguang Biotech Group Co akcijų skaičius CNE100000WC5 ·

Pardavimai, EBIT ir Pelnas vienai akcijai

Pajamos vienai akcijai

EBIT vienai akcijai

Pelnas vienai akcijai

Tikėtinos vertės

Chenguang Biotech Group Co Akcijų padalijimai

Chenguang Biotech Group Co akcijos dividendas CNE100000WC5 ·

Dividendas

Dividendų apžvalga

Interpretacija ir naudojimas

Investavimo strategija

Chenguang Biotech Group Co Dividendų istorija

Chenguang Biotech Group Co akcijų išmokėjimo koeficientas CNE100000WC5 ·

Dividendų mokėjimo rodiklis

Kas yra metinis dividendų mokėjimo rodiklis?

Kaip interpretuoti duomenis

Duomenų naudojimas investavimui

Chenguang Biotech Group Co Dividendų išmokėjimo istorija

Chenguang Biotech Group Co Pelno prognozės

Padaryk geriausias savo gyvenimo investicijas
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Akcijų kodas
300138.SZ

ISIN
CNE100000WC5